in sequential phase i/ii trials , 111 patients who were previously untreated for metastatic or inoperable sarcomas received doxorubicin , ifosfamide , dacarbazine at doses of 60 , 7,500 , and 900 mg/m2 , respectively , by cl over 72 hours ;
C1261473
sarcomas
C0020823
ifosfamide